News Conference News TCT 2024 EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis Michael O'Riordan October 28, 2024
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
News Conference News TCT 2021 iFR Matches FFR Through 5 Years: iFR-SWEDEHEART Caitlin E. Cox November 04, 2021
News Conference News TCT 2020 OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES L.A. McKeown October 17, 2020
News Conference News TCT 2019 SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis Marcus A. Banks September 27, 2019
Presentation TCT 2017 Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes October 30, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
Presentation TCT 2016 Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis and Restenosis: Are We Making Progress as Stents Evolve? Presenter: Fernando Alfonso, Stephan Windecker, Aloke V. Finn October 30, 2016
News Conference News TCT 2013 Novel Ischemia Measurement Strategies Show Potential vs. FFR October 30, 2013
News Conference News TCT 2013 Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease October 29, 2013